Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
- PMID: 9005747
- DOI: 10.7326/0003-4819-126-2-199701150-00006
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy
Abstract
Background: Loading doses of warfarin that are larger than those used for maintenance therapy are widely used in clinical practice, but they have never been prospectively evaluated.
Objective: To compare the effect of 5- and 10-mg loading doses of warfarin on laboratory markers of warfarin's anticoagulant effect.
Design: Randomized clinical trial.
Setting: Tertiary care teaching hospital.
Patients: 49 patients seen over a 5-month period with a target international normalized ratio (INR) of 2.0 to 3.0.
Intervention: Patients were randomly assigned to receive an initial dose of 5 or 10 mg of warfarin. Subsequent doses of warfarin were administered on the basis of dosing nomograms.
Measurements: INRs and levels of factors II, VII, IX, and X and protein C were measured daily for 5 days.
Results: 11 of 25 patients in the 10-mg group (44% [95% CI, 34% to 54%]) and 2 of 24 patients in the 5-mg group (8% [CI, 3% to 14%]) had INRs greater than 2.0 at 36 hours (P = 0.005), at which time the factor VII levels were 27% (CI, 18% to 36%) in the 10-mg group and 54% (CI, 43% to 65%) in the 5-mg group (P < 0.001). In contrast, factor II levels were 74% (CI, 67% to 81%) in the 10-mg group and 82% (CI, 73% to 93%) in the 5-mg group (P > 0.2). At 60 hours, 9 of 25 patients in the 10-mg group (36% [CI, 17% to 54%]) and no patients in the 5-mg group had INRs greater than 3.0. At 84 hours, 15 of 24 patients in the 10-mg group (63% [CI, 43% to 81%]) and 19 of 24 patients in the 5-mg group (79% [CI, 62% to 95%]) had INRs between 2.0 and 3.0. Four patients in the 10-mg group and 1 patient in the 5-mg group received vitamin K for excessive prolongation of the INR.
Conclusions: A 5-mg loading dose of warfarin produces less excess anticoagulation than does a 10-mg loading dose; the smaller dose also avoids the development of a potential hypercoagulable state caused by precipitous decreases in levels of protein C during the first 36 hours of warfarin therapy.
Comment in
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. doi: 10.7326/0003-4819-127-4-199708150-00015. Ann Intern Med. 1997. PMID: 9265436 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. doi: 10.7326/0003-4819-127-4-199708150-00016. Ann Intern Med. 1997. PMID: 9265437 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332; author reply 333. Ann Intern Med. 1997. PMID: 9265438 No abstract available.
-
Warfarin: less may be better.Ann Intern Med. 1997 Aug 15;127(4):332-3. Ann Intern Med. 1997. PMID: 9265439 No abstract available.
-
Randomized trial of warfarin nomograms.Ann Intern Med. 2004 Mar 16;140(6):489-90; author reply 491-2. doi: 10.7326/0003-4819-140-6-200403160-00026. Ann Intern Med. 2004. PMID: 15023723 No abstract available.
-
Randomized trial of warfarin nomograms.Ann Intern Med. 2004 Mar 16;140(6):491; author reply 491-2. doi: 10.7326/0003-4819-140-6-200403160-00029. Ann Intern Med. 2004. PMID: 15023726 No abstract available.
Similar articles
-
Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose.Circulation. 1968 Jul;38(1):169-77. doi: 10.1161/01.cir.38.1.169. Circulation. 1968. PMID: 11712286 Clinical Trial.
-
Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.Haematologica. 2002 Oct;87(10):1074-80. Haematologica. 2002. PMID: 12368163
-
Warfarin initiation and monitoring with clotting factors II, VII, and X.Ann Pharmacother. 2004 Feb;38(2):251-6. doi: 10.1345/aph.1D266. Epub 2003 Dec 30. Ann Pharmacother. 2004. PMID: 14742761
-
Warfarin therapy. 1.N Engl J Med. 1970 Sep 24;283(13):691-4. doi: 10.1056/NEJM197009242831307. N Engl J Med. 1970. PMID: 4916914 Review. No abstract available.
-
Warfarin therapy: evolving strategies in anticoagulation.Am Fam Physician. 1999 Feb 1;59(3):635-46. Am Fam Physician. 1999. PMID: 10029789 Review.
Cited by
-
Preliminary outcomes of preemptive warfarin pharmacogenetic testing at a large rural healthcare center.Am J Health Syst Pharm. 2019 Feb 21;76(6):387-397. doi: 10.1093/ajhp/zxy072. Am J Health Syst Pharm. 2019. PMID: 31415684 Free PMC article.
-
Effect of patient-specific factors on weekly warfarin dose.Ther Clin Risk Manag. 2007 Jun;3(3):499-504. Ther Clin Risk Manag. 2007. PMID: 18488070 Free PMC article.
-
Optimal loading dose for the initiation of warfarin: a systematic review.BMC Cardiovasc Disord. 2010 Apr 19;10:18. doi: 10.1186/1471-2261-10-18. BMC Cardiovasc Disord. 2010. PMID: 20403189 Free PMC article.
-
Short-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient Care.J Am Heart Assoc. 2016 Oct 31;5(11):e004065. doi: 10.1161/JAHA.116.004065. J Am Heart Assoc. 2016. PMID: 27799233 Free PMC article.
-
Pharmacogenetics and anticoagulant therapy.J Thromb Thrombolysis. 2003 Aug-Oct;16(1-2):73-8. doi: 10.1023/B:THRO.0000014598.24114.62. J Thromb Thrombolysis. 2003. PMID: 14760217 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical